GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » Float Percentage Of Total Shares Outstanding

Respiri (ASX:RSH) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 16, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Respiri Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Respiri's float shares is 0.00 Mil. Respiri's total shares outstanding is 1,059.87 Mil. Respiri's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Respiri's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Respiri's Institutional Ownership is 0.00%.


Respiri Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Respiri's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,059.87
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Respiri (ASX:RSH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
432 St Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

Respiri (ASX:RSH) Headlines

No Headlines